SecBot SecBot

CVS

CVS HEALTH Corp
NYSE· Retail-Drug Stores and Proprietary Stores· Inc. DE· CIK 0000064803 Consumer & Retail
$88.40 −0.95 (−1.06%)
Nov 16 4:00 PM ET · prev $89.35
Market cap
$114.9B
Large cap
Consensus
Buy
88% Buy or better · 32 analysts
Median target
🔒 Subscribers only
1 year
+12.7%
from $78.41 · Nov 17
30 days
−4.3%
from $92.36
52-week range
$70.08–110.60
−20% from high · low Mar 27
Avg volume 20D
11.07M
Nov 4 spike 34.29M
Short interest
17.88M
≈1.4% of shares · +10.4%
Days to cover
2.8
at average volume
Insider net
−$357.0M
1 buyer · 2 sellers · since Mar 31
New fund stakes
4
Q2 2026 13F · 3 exits
Reddit crowd
50°
Neutral · 2 mentions this week
SecBot read BULLISH 7 reports · 90 days
Balance 0 bearish · 2 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 5/7

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $2.0M at an average $83.90. 2 insiders sold $359.0M. Price is 5% above their cost.

  • InstitutionsMIXED

    Q2 2026: 61 added (4 new), 47 trimmed or exited. Largest new: Viking Global Investors $379.0M, Point72 Asset Management, $202.9M.

  • AnalystsBULLISH

    28 of 32 rate it Buy or better.

  • Short sellersSTEADY

    Short interest +10.4% to 17.88M shares. 2.8 days to cover, ≈1.4% of shares.

  • TrendDOWNTREND

    1% below its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 2 mentions: 0 bullish, 0 bearish. No setup is alerting. Excludes 1 subscriber-only day.

Who's buying

13F· Q2 2026
4
new positions
3
exits
$788.4M
in new stakes
FundMoveSharesValue
WELLINGTON MANAGEMENT GROUP LLPADD33,801,113$3.5B
BANK OF AMERICA CORP /DE/DOUBLED23,188,670$2.4B
JPMORGAN CHASE & COTRIM22,112,970$2.3B
GQG Partners LLCDOUBLED7,955,411$823.0M
RAYMOND JAMES FINANCIAL INCADD4,348,680$449.9M
WELLS FARGO & COMPANY/MNTRIM3,682,178$380.9M
VIKING GLOBAL INVESTORS LPNEW3,663,361$379.0M
Holocene Advisors, LPTRIM3,001,684$310.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

32 analysts
Buy 88% rate it Buy or better
Strong Buy8Buy20Hold4Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Nov 12, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Nov 5, 2026UBS
MAINTAIN
MAINTAINBuy
Nov 5, 2026Leerink Partners
MAINTAIN
MAINTAINOutperform
Nov 5, 2026Barclays
MAINTAIN
MAINTAINOverweight
Oct 12, 2026Leerink Partners
MAINTAIN
MAINTAINOutperform
Congressional trades
CVS trades disclosed by members of Congress, with disclosure delay.
5 members · 6 buys / 5 sells
DateMemberType AmountDisclosed
Oct 13, 2026 Ro KhannaDHouse Child account · CVS Health Corp SELL $1K–$15K Nov 5, 2026 +23d
Oct 13, 2026 Ro KhannaDHouse Spouse account · CVS Health Corp BUY $1K–$15K Nov 5, 2026 +23d
Sep 4, 2026 Ro KhannaDHouse Spouse account · CVS Health Corp SELL $15K–$50K Oct 7, 2026 +33d
May 15, 2026 Ro KhannaDHouse Spouse account · CVS Health Corp BUY $1K–$15K Jun 9, 2026 +25d
May 1, 2026 Ro KhannaDHouse Child account · CVS Health Corp BUY $1K–$15K Jun 9, 2026 +39d
Apr 13, 2026 Ro KhannaDHouse Spouse account · CVS Health Corp BUY $1K–$15K May 11, 2026 +28d
Feb 20, 2026 Michael McCaulRHouse Spouse account · CVS Health Corp BUY $15K–$50K Mar 12, 2026 +20d
Jan 29, 2026 John BoozmanRSenate Joint account · CVS Health Corp BUY $1K–$15K Feb 15, 2026 +17d
Jan 13, 2026 Michael McCaulRHouse Spouse account · CVS Health Corp SELL $15K–$50K Feb 11, 2026 +29d
Nov 21, 2025 Dwight EvansDHouse CVS Health Corp SELL $1K–$15K May 15, 2026 +175d

Insider ledger

Form 4
$2.0M
bought · 1 insider
$359.0M
sold · 2 insiders
+5.4%
vs their $83.90 cost
DateInsiderTypeValue
Nov 6, 2026
Shah Prem S
EVP and Group President
Nov 6, 2026
BUY$2.0M
Jun 26, 2026
Clark James David
SVP, Cont & Chief Acct Officer
Jun 26, 2026
TAX W/H$41.3K
May 31, 2026
Compton-Phillips Amy
EVP, Chief Medical Officer
May 31, 2026
TAX W/H$693.1K
May 31, 2026
Newman Brian
EVP, Chief Financial Officer
May 31, 2026
TAX W/H$225.4K
May 21, 2026
ROBBINS LARRY
Director
May 21, 2026
SELL$34.6M
May 21, 2026
ROBBINS LARRY
Director
May 21, 2026
SELL$35.3M
May 21, 2026
AGUIRRE FERNANDO
Director
May 21, 2026
TO ISSUER$146.1K
May 20, 2026
ROBBINS LARRY
Director
May 20, 2026
SELL$74.6M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 13, 2026
Enforcement
Zimniski v. CVS Health Corp.
Court ruling (caed). Docket: 2:19-cv-02257
Nov 13, 2026
Enforcement
Zimniski v. CVS Health Corp.
Court ruling (caed). Docket: 2:19-cv-02257
Nov 11, 2026
Company news
CVS Health earns global recognition for industry-leading AI and technology innovation
Seven Stevie® Awards honor innovations across enterprise AI portfolio, including clinical operations, disaster response and workforce development…
Nov 4, 2026
Earnings result
CVS Q3 2026 Earnings: EPS $2.09 (+25.4% vs est)
Oct 23, 2026
Press release
CVS Pharmacy expands fall assortment of collectibles, nostalgic favorites and seasonal exclusives
New and expanded offerings across toys, collectibles, beauty, snacks and seasonal categories give shoppers more opportunities to discover unexpected…

Washington

Corporate Lobbying

73 lobbying filings and 12 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
17,875,527
shares short
+10.4%
vs prior settlement
2.8
days to cover
≈1.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
The U.S. government and a coalition of 29 states declined to intervene in a False Claims Act qui tam lawsuit against…
COURT-RULING · Impact 3/10
Nov 13, 2026 Event
Zimniski v. CVS Health Corp.
Court ruling (caed). Docket: 2:19-cv-02257
Nov 11, 2026 Routine
CVS Health earns global recognition for industry-leading AI and technology innovation
Seven Stevie® Awards honor innovations across enterprise AI portfolio, including clinical operations
Nov 6, 2026 SEC
CVS EVP and Group President Prem S. Shah purchased $2.0M of stock on the open market two days after the company…
INSIDER-BUY · Impact 4/10
Nov 6, 2026 Insider
Shah Prem S bought 23,855 shares
EVP and Group President @ $83.90 ($2.0M)
Nov 4, 2026 SEC
CVS Health announced plans to separate into two independent publicly traded companies: a healthcare solutions company…
8-K · Impact 6/10
Oct 15, 2026 Press
CVS Health announced a collaboration with The Midlife Collective to conduct a research study on women's midlife…
Impact 2/10
Oct 13, 2026 Congress
Ro Khanna sell
$1,001 - $15,000 · House
Reddit Mentions per day, 14 days
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 2 0 in posts · 2 in comments
Recent posts
Recent comments
All social signals and their track records

SecBot reports

22 filings · 3 press releases · 8 bullish · 1 bearish · 13 neutral
All CVS filing & press-release reports (25)